Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Tax lots affect cost basis and gains in retirement accounts. This piece compares ETFs and mutual funds to help you choose.
25,093 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Cathie Wood built a name on bold bets in disruptive tech. This piece breaks down how ARK Innovation rode dramatic swi...
A diversified cybersecurity ETF now holds CrowdStrike alongside 30 other rivals, offering broad exposure as AI-driven...
Dover, New Hampshire blends small-town charm with walkable streets and strong services, drawing retirees who want ind...
Berkshire Hathaway owns a big slice of Apple, and that slice throws off dividend income. This deep dive breaks down w...
Global stock markets are diverging: broad global ETFs outperform the SPY while U.S. dynamics pose challenges. Here’s ...
Industry leaders urge a shift from hype to honest storytelling to rebuild trust in reverse mortgages. This report out...
A major fiscal analysis warns that Social Security could suffer a 24% across-the-board cut by 2032, costing about $50...
As inflation and market volatility persist into 2026, two smart social security claiming strategies help married coup...
A sudden fire in New Jersey claimed Paul Avery and his wife, a reminder that solid financial planning safeguards love...
H&R Block’s Q3 results set the tone for block (hrb) 2026 earnings. This guide breaks down the numbers, strategy, and ...
As volatility tests investors, three utility ETFs offer steady income with defensive exposure. Here’s how XLU, VPU, a...